How the Nobel discovery is used in drug development

Regulatory T cells keep the immune system in check, a discovery now awarded the 2025 Nobel Prize in Physiology or Medicine. Qiang Pan Hammarström explains how t...

Unmatched performance and flexibility in its class

The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.

Sarah Lidé: ”Artificial intelligence must not replace authentic interactions”

Artificial intelligence must never become a replacement for authentic, even if messy, interactions with our fellow humankind, Sarah Lifé, Deputy CEO at Medicon ...

Quretech granted a European patent for a new type of antibiotic

The European patent provides protection until 2041. Previously, the patent was granted in China, and the application is currently under review in the USA, India, and Japan.

FDA approves first non-opioid pain reliever in over 20 years

For the first time in decades, a new type of acute pain medication that is not an opioid has been approved in the USA.

FDA approves Gilead’s HIV injection: “Historic day”

Gilead Sciences’ preventive HIV drug, lenacapavir, was approved on Wednesday by the U.S. Food and Drug Administration (FDA), sparking new hope for finally break...

Björn Arvidsson will lead research and innovation in Region Uppsala

The Swedish life science profile Björn Arvidsson has been appointed Director of Research and Innovation for Region Uppsala.

HAB Nicolai Johannsen

Licenspartner backar ur – lämnar tillbaka projekt till Affibody

Affibody får tillbaka de globala rättigheterna till izokibeb sedan samarbetspartnern Acelyrin avbrutit sin utveckling av programmet.

Clinigen Clinical Supplies Management GmbH

Medical device quality assurance

Recordings from ZEISS Quality Innovation Days.

Abbvie växlar upp inom neuro – köper alzheimerföretag

Amerikanska Abbvie köper det Bostonbaserade företaget Aliada Therapeutics med läkemedelskandidater mot alzheimer. Affären blir det tredje stora förvärvet för Ab...

TECHNIA AB

The art of successful licensing – “A lot has to align”

Sharp research, strong data and a high level of innovation are all very good, but more than that is required to achieve the goal of many biotechnology companies...

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

Organize and Manage Digital Classrooms

Create engaging lessons with ZEISS Labscope Teacher.

Irlab når ny milstolpe för behandling mot apati

Forskningsbolaget Irlab Therapeutics får en milstolpsbetalning på 2,5 miljoner dollar, motsvarande cirka 26 miljoner kronor, sedan ett nytt steg tagits i utveck...

Behöver du vätskekylning under noll grader?

SMC erbjuder cirkulationskylare för en rad olika appikationer och temperaturer, minusgrader inkluderat. Kontakta oss så hittar vi rätt lösning för dig!

Learn from Speakers from Leading MedTech Companies

Watch the recordings from ZEISS Quality Innovation Days whenever it suits you.

Level up your medical expertise

Learn from innovative industry speakers from leading MedTech companies at ZEISS Quality Innovation Days.

Dansk aktör köper krisande amerikanskt cancerbolag

Danska Pharmacosmos tar över det amerikanska läkemedelsbolaget G1 Therapeutics i en affär som uppgår till 405 miljoner dollar.

Obesity-drug pioneers win Lasker Award

This year’s Lasker Prize in Clinical Research has been awarded to three researchers for their discoveries in GLP-1-based drugs that, according to the jury, “hav...

Danish biotech to buy struggling American oncology company

Danish drugmaker Pharmacosmos has agreed to acquire American pharmaceutical company G1 Therapeutics in a deal that amounts to 405 million dollars.